Long COVID as a network disorder: a mechanism-anchored framework for biological stratification and therapeutic targeting
-
By
-
Robert Groysman
-
May 29, 2026
-
Clinical Scorecard: Understanding Long COVID as a Network Disorder: A Framework for Biological Stratification and Targeted Therapies
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | Biologically heterogeneous condition involving autonomic dysfunction, mitochondrial impairment, endothelial dysfunction, gut dysbiosis, mast cell signaling, neuroendocrine dysregulation, persistent immune activation, and viral antigen persistence. |
| Target Population | |
| Care Setting | |
Key Highlights
- Long COVID is characterized by a wide variability in symptom expression and treatment response.
- Symptom-based phenotyping may not accurately reflect shared biological mechanisms.
- A mechanism-anchored framework is proposed to improve understanding and treatment of Long COVID.
- Primary domains include autonomic dysfunction, mitochondrial impairment, and endothelial dysfunction.
- Secondary processes like persistent immune activation, viral antigen persistence, and neuroinflammation may amplify symptoms.
Guideline-Based Recommendations
Diagnosis
Management
- Consider biologically measurable domains for targeted therapies, including specific interventions based on identified mechanisms.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Individuals with diverse symptom presentations following COVID-19.
Therapeutic cohorts should be stratified based on biological mechanisms rather than solely symptom clusters.
Clinical Best Practices
- Employ a network-based approach to understand symptom persistence.
- Integrate physiological assessments into clinical evaluations.
- Facilitate research on biologically enriched cohorts for improved treatment outcomes.
- Prospective validation of the mechanism-anchored framework is essential for clinical applicability.
Related Resources & Content
